AbCellera Biologics Inc. — All Filings
290 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001834449-26-000004 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001834449-26-000002 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0001834411-26-000004 | Feb 27, 2026 | — |
| S-8 | S-8 | 0001703057-26-000013 | Feb 24, 2026 | — |
| 10-K | 10-K | 0001703057-26-000012 | Feb 24, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001703057-26-000010 | Feb 24, 2026 | — |
| 8-K | 8-K | 0001703057-26-000003 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | FORM 4 | 0001834411-26-000002 | Jan 5, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001834412-26-000002 | Jan 5, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001834424-26-000002 | Jan 5, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001834418-26-000002 | Jan 5, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001685889-25-000008 | Dec 19, 2025 | Dec 1, 2025 |
| 3 | FORM 3 | 0001685889-25-000006 | Dec 19, 2025 | Nov 10, 2025 |
| 4 | FORM 4 | 0001834449-25-000004 | Dec 19, 2025 | Dec 18, 2025 |
| 8-K | 8-K | 0001703057-25-000034 | Dec 18, 2025 | — |
| 8-K | 8-K | 0001703057-25-000032 | Nov 28, 2025 | Nov 24, 2025 |
| 4 | FORM 4 | 0001834423-25-000004 | Nov 26, 2025 | — |
| 8-K | 8-K | 0001703057-25-000029 | Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | 10-Q | 0001703057-25-000025 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001703057-25-000024 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001703057-25-000018 | Sep 10, 2025 | — |
| 10-Q | 10-Q | 0001703057-25-000011 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001628280-25-038927 | Aug 7, 2025 | — |
| 4 | FORM 4 | 0001628280-25-033735 | Jul 1, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001628280-25-031647 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001628280-25-031646 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0001628280-25-031219 | Jun 13, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0001628280-25-028529 | May 30, 2025 | — |
| 8-K | 8-K | 0001628280-25-025573 | May 14, 2025 | — |
| 8-K | 8-K | 0001628280-25-025006 | May 13, 2025 | May 12, 2025 |
| 10-Q | 10-Q | 0001628280-25-023836 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-023808 | May 8, 2025 | — |
| ARS | ARS | 0001628280-25-020746 | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001628280-25-020729 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0001628280-25-020703 | Apr 29, 2025 | Dec 31, 2024 |
| 4 | FORM 4 | 0001628280-25-012154 | Mar 11, 2025 | — |
| 4 | FORM 4 | 0001628280-25-011750 | Mar 10, 2025 | — |
| 4 | FORM 4 | 0001628280-25-011254 | Mar 7, 2025 | Mar 6, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-039391 | Feb 27, 2025 | — |
| S-8 | S-8 | 0001628280-25-008708 | Feb 27, 2025 | — |
| 10-K | 10-K | 0001628280-25-008689 | Feb 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001628280-25-008650 | Feb 27, 2025 | — |
| 8-K | 8-K | 0001628280-25-005983 | Feb 18, 2025 | — |
| 4 | FORM 4 | 0001628280-25-000237 | Jan 3, 2025 | Jan 1, 2025 |
| 4 | FORM 4 | 0001628280-25-000235 | Jan 3, 2025 | Jan 1, 2025 |
| 4 | FORM 4 | 0001628280-25-000233 | Jan 3, 2025 | Jan 1, 2025 |
| 4 | FORM 4 | 0001628280-25-000232 | Jan 3, 2025 | Jan 1, 2025 |
| 4 | FORM 4 | 0001628280-24-050097 | Dec 5, 2024 | Dec 4, 2024 |
| 4 | FORM 4 | 0001628280-24-049327 | Nov 26, 2024 | Nov 25, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-118908 | Nov 14, 2024 | — |